We provide specialized drug product development for pediatric and geriatric populations. We offer a full range of multiparticulate technologies, as well as chewable and orally disintegrating tablet options, and expertise in taste and odor masking. Our integrated solutions provide for API, drug product intermediates and specialized drug products from feasibility to commercial manufacture.
Driven by regulatory requirements in North America and Europe, pediatric product development continues to increase rapidly. Development must take into account the patient sub-populations within the pediatric spectrum, from neo-natal to late teenage groups. Pediatric product development must also take into account the needs of the care giver, (e.g. ease of administration), as well as the patient.